title: Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus.
abstract: OBJECTIVE
  Cardiac manifestations of neonatal lupus, comprising atrioventricular conduction defects and cardiomyopathy, occur in fetuses exposed to anti-Ro/SSA antibodies, and carry substantial mortality. There is strong evidence of a genetic contribution to the risk. This study was undertaken to evaluate single-nucleotide polymorphisms (SNPs) for associations with cardiac neonatal lupus.
  
  
  METHODS
  Children of European ancestry with cardiac neonatal lupus (n = 116) were genotyped using the Illumina 370K SNP platform and merged with 3,351 controls. Odds ratios (ORs) and 95% confidence intervals (95% CIs) for association with cardiac neonatal lupus were determined.
  
  
  RESULTS
  The 17 most significant associations with cardiac neonatal lupus were found in the HLA region. The region near the MICB gene showed the strongest variant (rs3099844; P(dom) = 4.52 × 10(-10) , OR 3.34 [95% CI 2.29-4.89]), followed by a missense variant within C6orf10 (rs7775397; P(dom) = 1.35 × 10(-9) , OR 3.30), which lies between NOTCH4 and BTNL2, and several SNPs near the tumor necrosis factor α gene, including rs2857595 (P(add) = 1.96 × 10(-9) , OR 2.37), rs2230365 (P(add) = 1.00 × 10(-3) , OR 0.46), and rs3128982 (P(add) = 6.40 × 10(-6) , OR 1.86). Outside the HLA region, an association was detected at 21q22, upstream of the transcription regulator ets-related isoform 1 (rs743446; P = 5.45 × 10(-6) , OR 2.40). HLA notwithstanding, no individual locus previously implicated in autoimmune diseases achieved genome-wide significance.
  
  
  CONCLUSIONS
  These results suggest that variation near genes related to inflammatory and apoptotic responses may promote cardiac injury initiated by passively acquired autoantibodies.
authors.affiliation: New York University Langone School of Medicine, New York, New York 10003, USA. bobdclancy@aol.com
authors.forename: Robert M
authors.initials: RM
authors.lastname: Clancy
authors.forename: Miranda C
authors.initials: MC
authors.lastname: Marion
authors.forename: Kenneth M
authors.initials: KM
authors.lastname: Kaufman
authors.forename: Paula S
authors.initials: PS
authors.lastname: Ramos
authors.forename: Adam
authors.initials: A
authors.lastname: Adler
authors.forename: John B
authors.initials: JB
authors.lastname: Harley
authors.forename: Carl D
authors.initials: CD
authors.lastname: Langefeld
authors.forename: Jill P
authors.initials: JP
authors.lastname: Buyon
mesh_terms: D002891:Chromosomes, Human, Pair 21 / Q000235:genetics*; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D055106:Genome-Wide Association Study; D005838:Genotype; D006331:Heart Diseases / Q000150:complications / Q000151:congenital / Q000235:genetics*; D006801:Humans; D007231:Infant, Newborn; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000151:congenital / Q000235:genetics*; D008297:Male; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012042:Registries